Oral anticoagulation in chronic kidney disease with atrial fibrillation
Chronic kidney disease (CKD) and atrial fibrillation (AF) frequently coexist, amplifying the risk of cardiovascular events and mortality. In patients with CKD stage 3 and non-valvular AF, direct oral anticoagulants (DOACs) have shown, compared to vitamin K antagonists (VKA), equal or greater efficac...
Main Authors: | Pablo Gomez -Fernández, Antonio Martín Santana, Juan de Dios Arjona Barrionuevo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-03-01
|
Series: | Nefrología (English Edition) |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2013251421000365 |
Similar Items
-
Nuevos anticoagulantes orales en pacientes con enfermedad renal crónica
by: Lara Belmar Vega, et al.
Published: (2017-05-01) -
NUEVOS ANTICOAGULANTES ORALES EN FIBRILACIÓN AURICULAR
by: Dra. E. Marianella Seguel R.
Published: (2015-03-01) -
Patrón tromboelastográfico en pacientes anticoagulados con rivaroxabán por fibrilación auricular
by: Susana Pacheco Jaramillo, et al.
Published: (2016-11-01) -
Seguridad del cateterismo diagnóstico ambulatorio en pacientes en tratamiento con anticoagulantes orales de acción directa
by: Cristina Ramírez Guijarro, et al.
Published: (2019-08-01) -
Costo-efectividad de dabigatrán comparado con warfarina para el tratamiento de pacientes con fibrilación auricular no valvular
by: Juan J. Triana, et al.
Published: (2016-03-01)